EDMONTON, AB, July 26, 2021 /CNW/ - PRESS RELEASE - Aurora Cannabis Inc., a Canadian cannabis company, announced today the appointment of Theresa Firestone to the company's Board of Directors, effective today. This is a newly created directorship that expands the Board to nine members, seven of whom are independent.

Firestone joins the Board following a distinguished career as a senior healthcare executive with leadership positions in Canada, Europe and Asia. An expert in strategic planning, operations and new business development, Firestone has served in various sectors such as retail, healthcare, pharmaceuticals and government. Her experience includes over 20 years of international P&L management, 15 years in senior roles at Pfizer Inc., over ten years at the Ontario Ministry of Health and seven years in retail and health and wellness, including Shoppers Drug Mart where she oversaw the design and launch of the company's Medical Cannabis business. In addition, Firestone has more than 20 years of public and private board experience including with Orion Biotechnology, Merus Labs International and several not-for-profit organizations.

Ronald Funk, Chairman of Aurora Cannabis, stated, "We are delighted to welcome Theresa to our Board of Directors. She brings to us extensive expertise in healthcare management and pharmaceuticals, global business restructuring, new business development and a proven ability to lead and manage change. Her background and well-defined skillset will be invaluable to us as we execute our strategic growth plans while managing costs more effectively. We look forward to benefitting from her many contributions to Aurora."

Firestone holds a Bachelor of Applied Science from the University of Guelph and completed the Executive Leadership Program at Harvard Business School. Accolades include induction into the Canadian Healthcare Marketing Hall of Fame, honored as one of 12 Outstanding Canadian Women by the Weizman Institute and awarded the prestigious Queen's Golden Jubilee medal.